SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jul 9, 2026

HALO

HALOZYME THERAPEUTICS, INC.
NEUTRAL
Impact 2/10
Horizonweeks Processed4mo ago
Insider cluster: 2 insiders, $147K total
Actionable Insight • Neutral

Insider selling is negligible in scale and follows a routine cashless-exercise pattern. No bearish signal for the common stock. Monitor the next 10-Q for fundamentals and pipeline updates, which are the true catalysts for HALO at this valuation.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$76.20
T+0 close · Jul 9, 2026 · via day close
Latest settled
+42.14%
T+60 · $108.31
Vs SPY
+39.51%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 10 $76.20entry
  2. T+1 · 4mo ago −0.12%α +0.65% · $76.11
  3. T+5 · 4mo ago +2.11%α +3.66% · $77.81
  4. T+20 · 3mo ago +35.33%α +32.90% · $103.12
  5. T+60 · 6w ago +42.14%α +39.51% · $108.31
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Helen Torley sold $153K in stock after exercising derivative shares at $12.07, netting a substantial cashless-settlement gain. Director Bernadette Connaughton also sold $76K. The $229K total open-market sales represent ~0.002% of HALO's $9.5B market cap, well below any materiality threshold. The CEO's sales are consistent with routine tax-settlement and diversification, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$229.0K
Insiders
2

Key Facts

  • CEO Torley exercised 1,923 derivative shares at $12.07 and simultaneously sold 1,923 shares ($153K total) at ~$80, a classic cashless exercise pattern
  • Director Connaughton sold 1,000 shares at $76.39 for $76K
  • Total open-market sales of $229K equal ~0.002% of $9.5B market cap
  • Prior 30-day insider activity showed $278K in sales, this cluster is a continuation of routine, small-dollar selling

Financial Impact

Total open-market sales of $229K, representing approximately 0.002% of market capitalization, economically trivial

Risk Factors

  • Insider sales, even small, may be misinterpreted by retail as a negative signal
  • If current selling accelerates beyond $300K/month or involves C-suite without offsetting buys, revisit

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
69% bullish (16 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-HALO-1783670523088

Track record

15 reports on HALO

Performance horizon

1 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +17.70% at T+20 after the Oct 15, 2026 report. 4 of 6 went positive at some point.

Filters
  1. Nov 9, 20268d ago PTAB Trial Bearish 6/10 Entry $102.98 Now $96.50 +6.29% settles Nov 17
  2. Nov 6, 202610d ago Press Release Bullish 6/10 Entry $103.63 to $100.27 Now $96.50 −6.88% ▼ −3.24% −5.84% vs SPY
  3. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $103.63 to $100.27 Now $96.50 −6.88% ▼ −3.24% −5.84% vs SPY
  4. Oct 22, 202625d ago Press Release Neutral 1/10 Entry $124.54 to $131.18 Now $96.50 −22.51% ▲ +5.33% +4.62% vs SPY
  5. Oct 20, 202627d ago Institutional Cluster Bullish 4/10 Entry $124.83 to $128.50 Now $96.50 −22.69% ▲ +2.94% +3.38% vs SPY
  6. Oct 15, 20264w ago PTAB Trial Bearish 7/10 Entry $121.84 to $125.63 Now $96.50 +20.80% ▼ −3.11% −3.54% vs SPY
  7. Oct 15, 20264w ago PTAB Trial Bearish 7/10 Entry $121.84 to $125.63 Now $96.50 +20.80% ▼ −3.11% −3.54% vs SPY
  8. Sep 18, 20268w ago 8-K Mixed 6/10 Entry $112.45 to $113.90 Now $96.50 −14.18% ▲ +1.29% +0.02% vs SPY
  9. Sep 17, 20268w ago Insider Cluster Neutral 2/10 Entry $112.45 to $113.90 Now $96.50 −14.18% ▲ +1.29% +0.02% vs SPY
  10. Aug 19, 202612w ago Insider Cluster Neutral 2/10 Entry $106.12 to $106.92 Now $96.50 −9.07% ▲ +0.75% −0.36% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens in 7h 2m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 10, 2026